Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the effectiveness of oral midazolam on the delivery of care in elderly patients with moderat to severe neurocognitive disorders and opposing care.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Grenoble
NCT05508789 · Alzheimer Disease, Dementia, and more
NCT05668598 · Memory Disorders, Neurocognitive Disorders
NCT06853405 · Cognitive Dysfunction, Cognition Disorder, and more
NCT05741853 · Primary Progressive Aphasia, Dementia, and more
NCT07205003 · Neurocognitive Disorders, Alzheimer's Disease
Geriatric department of Grenoble Alpes university hospital
Grenoble, Isere
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions